Related references
Note: Only part of the references are listed.Apelin and Elabela/Toddler; double ligands for APJ/Apelin receptor in heart development, physiology, and pathology
Keiji Kuba et al.
PEPTIDES (2019)
A New Secretory Peptide of Natriuretic Peptide Family, Osteocrin, Suppresses the Progression of Congestive Heart Failure After Myocardial Infarction
Takahiro Miyazaki et al.
CIRCULATION RESEARCH (2018)
Pulmonary hypertension associated with left heart disease: Updated Recommendations of the Cologne Consensus Conference 2018
Stephan Rosenkranz et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Cardiac procholecystokinin expression during haemodynamic changes in the mammalian heart
Jens P. Goetze et al.
PEPTIDES (2018)
Endothelin
Anthony P. Davenport et al.
PHARMACOLOGICAL REVIEWS (2016)
Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure
John J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Novel Regulation of Cardiac Metabolism and Homeostasis by the Adrenomedullin-Receptor Activity-Modifying Protein 2 System
Takahiro Yoshizawa et al.
HYPERTENSION (2013)
Apelin is a positive regulator of ACE2 in failing hearts
Teruki Sato et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Ghrelin and cardiovascular diseases
Ichiro Kishimoto et al.
JOURNAL OF CARDIOLOGY (2012)
Current biochemistry, molecular biology, and clinical relevance of natriuretic peptides
Toshio Nishikimi et al.
JOURNAL OF CARDIOLOGY (2011)
Osteocrin is a specific ligand of the natriuretic peptide clearance receptor that modulates bone growth
Pierre Moffatt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The role of natriuretic peptides in cardioprotection
T Nishikimi et al.
CARDIOVASCULAR RESEARCH (2006)
Natriuretic peptide receptor-C signaling and regulation
MB Anand-Srivastava
PEPTIDES (2005)
Hemodynamic, renal, and hormonal effects of adrenomedullin infusion in patients with congestive heart failure
N Nagaya et al.
CIRCULATION (2000)
Share Paper
